SOD1 and Parkinson disease: Increases in atypical SOD1 PTMs that promote its aggregation may be compounded by dysregulation of SOD1 glycosylation in the Parkinson disease SNc, which likely signifies disruption of nascent, immature SOD1 trafficking [68].